Having gained FDA clearance for adult use of its novel catheters and guidance system, Imricor now can tackle the US paediatric market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results